BCAX Bicara Therapeutics Inc.
Price Chart
Executive Summary
Bicara Therapeutics granted a stock option to purchase 44,175 shares to a new employee as an inducement to join the company. The award was made outside of its shareholder-approved plans under the 2026 Inducement Plan, consistent with Nasdaq rules.
Actionable Insight
Monitor for additional inducement grants or insider activity; this isolated grant is routine for biotech firms and unlikely to move the stock. However, recent insider selling of $305K over 30 days may signal caution.
Key Facts
- Bicara Therapeutics granted a non-qualified stock option to purchase 44,175 shares to a new employee on April 1, 2026.
- The option has an exercise price of $20.50 per share, equal to the closing price on the grant date.
- Vesting: 25% on first anniversary, remaining 75% over 12 equal quarterly installments.
- Grant made under the 2026 Inducement Plan, approved by independent directors, outside shareholder-approved equity plans.
- No financial metrics, revenue, or earnings impact disclosed.
Financial Impact
Minimal near-term financial impact; potential for minor dilution from 44,175 shares.
Risk Factors
- Potential for incremental dilution if multiple such grants occur.
- Insider selling trend may contrast with positive messaging around hiring.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3267999 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 26, 2026
14d ago
|
Insider Cluster
| $21.58 $20.00 | ▼ −7.32% | ▼ −7.79% | $20.56 (−4.73%) |
|
May 11, 2026
29d ago
|
8-K
| $22.92 $19.29 | ▼ −15.84% | ▼ −15.75% | $20.56 (−10.30%) |
|
May 4, 2026
5w ago
|
Press Release
| $22.72 $22.92 | ▲ +0.88% | ▼ −2.06% | $20.56 (−9.51%) |
|
Apr 27, 2026
6w ago
|
DEFA14A
| $22.48 $22.72 | ▲ +1.09% | ▲ +0.69% | $20.56 (−8.52%) |
|
Apr 20, 2026
7w ago
|
Insider Cluster
| $21.28 $23.78 | ▲ +11.75% | ▲ +8.64% | $20.56 (−3.38%) |
|
Apr 15, 2026
8w ago
|
Insider Cluster
| $23.72 $23.63 | ▼ −0.38% | ▼ −2.02% | $20.56 (−13.32%) |
|
Apr 15, 2026
8w ago
|
Insider Cluster
| $23.72 $23.63 | ▲ +0.38% | ▲ +2.02% | $20.56 (+13.32%) |
|
Apr 3, 2026
9w ago
|
Press Release
| $20.85 $22.14 | ▲ +6.19% | ▲ +2.05% | $20.56 (−1.39%) |
|
Mar 23, 2026
11w ago
|
Press Release
| $18.39 $19.04 | ▲ +3.53% | ▲ +7.10% | $20.56 (+11.80%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $19.40 $18.39 | ▼ −5.21% | ▼ −3.16% | $20.56 (+5.98%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access